Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
Intra-Cellular Therapies, Watford Holdings: Top Stock Gainers for Wednesday
By Rob Lenihan
Sep 9, 2020 4:20 PM EDT
PRESS RELEASES
Intra-Cellular Therapies To Present At The 39th Annual J.P. Morgan Healthcare Conference
By GlobeNewswire
Jan 5, 2021 8:00 AM EST
PRESS RELEASES
Intra-Cellular Therapies To Present At The Evercore ISI 3rd Annual HealthCONx Conference
By GlobeNewswire
Nov 30, 2020 8:00 AM EST
PRESS RELEASES
Intra-Cellular Therapies To Host Third Quarter 2020 Financial Results Conference Call And Webcast
By GlobeNewswire
Nov 4, 2020 8:00 AM EST
PRESS RELEASES
Intra-Cellular Therapies Announces The Appointment Of Dr. Suresh Durgam As Chief Medical Officer
By GlobeNewswire
Oct 1, 2020 4:30 PM EDT
PRESS RELEASES
Intra-Cellular Therapies To Present At The Morgan Stanley 18th Annual Global Healthcare Conference
By GlobeNewswire
Sep 15, 2020 8:00 AM EDT
PRESS RELEASES
Intra-Cellular Therapies To Present At The Cantor Virtual Global Healthcare Conference
By GlobeNewswire
Sep 14, 2020 8:00 AM EDT
PRESS RELEASES
Intra-Cellular Therapies Prices Public Offering Of Common Stock
By GlobeNewswire
Sep 10, 2020 8:30 PM EDT
STOCKS
Intra-Cellular Therapies, Watford Holdings: Top Stock Gainers for Wednesday
By Rob Lenihan
Sep 9, 2020 4:20 PM EDT
PRESS RELEASES
Intra-Cellular Therapies Announces Proposed Public Offering Of Common Stock
By GlobeNewswire
Sep 9, 2020 4:01 PM EDT
PRESS RELEASES
Intra-Cellular Therapies Announces Positive Topline Results From Study 402 Evaluating Lumateperone As Adjunctive Therapy In Patients With Bipolar Depression
By GlobeNewswire
Sep 9, 2020 7:00 AM EDT
PRESS RELEASES
Intra-Cellular Therapies To Host Second Quarter 2020 Financial Results Conference Call And Webcast
By GlobeNewswire
Aug 4, 2020 8:00 AM EDT
PRESS RELEASES
Intra-Cellular Therapies To Present At The 2020 RBC Capital Markets Global Healthcare Conference
By GlobeNewswire
May 14, 2020 8:00 AM EDT
PRESS RELEASES
Intra-Cellular Therapies To Host Virtual Annual Meeting Of Stockholders
By GlobeNewswire
May 13, 2020 4:15 PM EDT
PRESS RELEASES
Intra-Cellular Therapies To Host First Quarter 2020 Financial Results Conference Call And Webcast
By GlobeNewswire
Apr 29, 2020 8:00 AM EDT
PRESS RELEASES
Intra-Cellular Therapies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Apr 16, 2020 4:45 PM EDT
PRESS RELEASES
Intra-Cellular Therapies Initiates Promotional Activities For CAPLYTA™ (lumateperone) For The Treatment Of Schizophrenia In Adults
By GlobeNewswire
Apr 2, 2020 8:00 AM EDT
PRESS RELEASES
Intra-Cellular Therapies To Host Fourth Quarter And Full Year 2019 Financial Results Conference Call And Webcast
By GlobeNewswire
Feb 24, 2020 8:00 AM EST
PRESS RELEASES
Intra-Cellular Therapies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Feb 21, 2020 4:15 PM EST
PRESS RELEASES
Pivotal Study Of CAPLYTA™ (lumateperone) For The Treatment Of Schizophrenia In Adults Published In JAMA Psychiatry
By GlobeNewswire
Feb 20, 2020 5:00 PM EST
PRESS RELEASES
Intra-Cellular Therapies To Present At The 9th Annual SVB Leerink Global Healthcare Conference
By GlobeNewswire
Feb 18, 2020 8:00 AM EST
STOCKS
Intra-Cellular Leaps on Signs of Fewer Side Effects With Schizophrenia Drug
By William McConnell
Sep 7, 2017 9:29 AM EDT
STOCKS
Intra-Cellular Evades Scrutiny on Schizophrenia Drug Safety, Shares Plunge
By Adam Feuerstein
May 1, 2017 11:22 AM EDT
HEALTH
Biotech Movers: Intra-Cellular Therapies, Organovo, Acorda
By Armie Margaret Lee
May 1, 2017 9:45 AM EDT
INVESTING
The 'Gnarly 9' biotechs will test FDA mettle
By Adam Feuerstein
Mar 8, 2017 12:40 PM EST
